Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
SRAX Inc is an advertising agencies business based in the US. SRAX shares (SRAX) are listed on the NASDAQ and all prices are listed in US Dollars. SRAX employs 158 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $3.22 |
|---|---|
| 52-week range | $3.00 - $6.50 |
| 50-day moving average | $3.64 |
| 200-day moving average | $4.68 |
| Wall St. target price | $11.33 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.97 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.22 from 2022-06-28
| 1 week (2022-06-23) | -5.29% |
|---|---|
| 1 month (2022-05-26) | -7.74% |
| 3 months (2022-03-30) | -31.78% |
| 6 months (2021-12-30) | -29.07% |
| 1 year (2021-06-30) | -40.81% |
|---|---|
| 2 years (2020-06-30) | 26.77% |
| 3 years (2019-06-28) | 4.66 |
| 5 years (2017-06-29) | 163.93% |
| Revenue TTM | $26 million |
|---|---|
| Gross profit TTM | $6.1 million |
| Return on assets TTM | -7.98% |
| Return on equity TTM | -87.05% |
| Profit margin | -78.87% |
| Book value | $0.89 |
| Market capitalisation | $92.2 million |
TTM: trailing 12 months
We're not expecting SRAX to pay a dividend over the next 12 months.
SRAX's shares were split on a 1:5 basis on 19 September 2016. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SRAX shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for SRAX shares which in turn could have impacted SRAX's share price.
Over the last 12 months, SRAX's shares have ranged in value from as little as $3 up to $6.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SRAX's is 1.9061. This would suggest that SRAX's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
SRAX, Inc. , a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.